FDA Holds Workshop on August 1, 2016--"Partnering with Patients on CDRH’s Research Agenda for Assistive Technologies and/or Neurostimulation Devices”

Partnering with Patients on CDRH’s Research Agenda for Assistive and/or Neurostimulation Devices

The Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) is announcing an interactive, in-person workshop entitled “Partnering with Patients on CDRH’s Research Agenda for Assistive and/or Neurostimulation Devices.”

The purpose of this workshop is to receive feedback on patient needs and experience regarding the usability, benefits, and desired features of medical devices to inform the regulatory science research agenda at the CDRH.  This workshop will focus on Assistive and Neurostimulation devicesassociated with sub-populations of the following diseases as examples:

·        Diabetes

·        Lupus

·        Macular Degeneration

·        Neurological Diseases

The interactive sessions will involve patients who wear these devices; providers, caregivers, clinicians, and medical personnel who work with these patients.

***There is no fee to register for the Workshop and registration will be on a first-come, first-served basis. Seating is limited so early registration is recommended.

Date, Time Location, Website, and Deadline

·        Date: August 1, 2016

·        Time: 8:30am – 5:00pm, EDT

·        Location: FDA (White Oak Campus), 10903 New Hampshire Avenue, Bldg. 31, Room 1503 (the Great Room), Silver Spring, MD, 20993

·        Website: http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm508481.htm

     Registration Deadline: 4:00 pm (ET), on July 26, 2016

Helene Clayton-Jeter, O.D.
Office of Health and Constituent Affairs
Food and Drug Administration

For more information about the Cardiovascular & Endocrine Liaison Program visit the FDA Patient Network